Related Experiment Video
Updated: Feb 24, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Plasma metabolomic profiling and functional disability in older adults
Andrés Pombo-Jiménez1, Damián González-Beltrán1, Humberto Yévenes-Briones1
1Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Plasma metabolites like lactate and creatinine may indicate functional decline in older adults. Certain metabolites are linked to increased or decreased odds of activities of daily living disability over time.
Area of Science:
- Gerontology
- Metabolomics
- Public Health
Background:
- Functional disability is a significant public health issue in older adults, predicting adverse outcomes.
- The relationship between metabolomic profiles and functional disability is not well understood.
Purpose of the Study:
- To investigate the associations between plasma metabolomic profiles and functional disability in older adults.
- To identify potential early biomarkers for functional decline.
Main Methods:
- The study included 1450 community-dwelling adults aged 65 years and older.
- Plasma metabolites were measured using high-throughput nuclear magnetic resonance spectroscopy.
- Disability was assessed using the Katz Index (ADL) and Lawton-Brody Scale (IADL), with analyses using Firth logistic regression for cross-sectional and longitudinal associations.
Main Results:
- Cross-sectionally, tyrosine, pyruvate, and lactate were associated with lower odds of ADL disability, while glycine and Glycoprotein A (GlycA) were linked to higher odds.
- Longitudinally, increased lactate predicted greater ADL disability after five years, whereas creatinine was associated with lower odds of both ADL and IADL disability.
- Incident disability analyses showed that higher creatinine and citrate predicted lower odds of ADL disability, and GlycA remained associated with higher odds of IADL disability.
Conclusions:
- Several plasma metabolites show potential as early biomarkers for functional decline in older adults.
- These findings could inform the development of targeted prevention strategies for functional disability.
More Related Videos
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption